Opaleye Management Inc. has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $390 Million distributed in 51 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Harrow Health, Inc. with a value of $83.4M, Tg Therapeutics, Inc. with a value of $40.6M, Ocular Therapeutix, Inc with a value of $36.3M, Rhythm Pharmaceuticals, Inc. with a value of $21.1M, and Keros Therapeutics, Inc. with a value of $16.8M.

Examining the 13F form we can see an decrease of $20.5M in the current position value, from $411M to 390M.

Opaleye Management Inc. is based out at Boston, MA

Below you can find more details about Opaleye Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $390 Million
Healthcare: $390 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 51
  • Current Value $390 Million
  • Prior Value $411 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 10 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.